Alterations in classical cadherins associated with progression in ulcerative and Crohn's colitis

Laboratory Investigation

Volumn 78, Issue 9, 1998, Pages 1155-1167

  Jankowski, J A Z ^a,b   Bedford, F K ^a   Boulton, R A ^a   Cruickshank, N ^a   Hall, C ^c   Elder, J ^c   Allan, R ^a   Forbes, A ^d   Kim, Y S ^b   Wright, N A ^a   Sanders, D S A ^e  

^a IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY HOSPITAL OF NORTH STAFFORDSHIRE   (United Kingdom)

^d ST MARK S HOSPITAL   (United Kingdom)

^e UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CADHERIN; UVOMORULIN;

ARTICLE; COLITIS; COLON CARCINOGENESIS; COLORECTAL CARCINOMA; CROHN DISEASE; DISEASE COURSE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; POINT MUTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; ULCERATIVE COLITIS;

ADULT; AGED; CADHERINS; COLITIS, ULCERATIVE; CROHN DISEASE; DISEASE PROGRESSION; DNA MUTATIONAL ANALYSIS; HUMANS; MIDDLE AGED; NUCLEOTIDES; REFERENCE VALUES; TUMOR CELLS, CULTURED;

EID: 0031710227     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (68)

1. Becker K-F, Atkinson MJ, Reich U, Becker I, Nekarda H, Sewiert JR, and Hofler H (1994). E-cadherin gene mutations provide clues in diffuse type gastric carcinomas. Cancer Res 54:3845-3852.
2. Bedford FK and Jankowski J (1995). Gene analysis and manipulation of the E-cadherin gene in clinical tissue. J Clin Pathol 48:M6-M11.
3. Behrens J, Lowerick O, Klein-Hitpass L, and Birchmeier W (1991). The E-cadherin promoter: Functional analysis of a GC rich region and an epithelial specific palindromic regulatory element. Proc Natl Acad Sci USA 88:11495-11499.
4. Behrens J, Mareel MM, Van RF, and Birchmeier W (1989). Dissecting tumor cell invasion; epithelial cells acquire invasive properties after the loss of uvomorulin-mediated cell-cell adhesion. J Cell Biol 108:2435-2449.
5. Behrens J, Vakaet L, Friis R, Winterhager E, Van Roy F, Mareel MM, and Birchmeier W (1993). Loss of epithelial differentiation and gain of invasiveness correlates with tyrosine phosphorylation of the E-cadherin/beta-catenin complex in cells transformed with a temperature sensitive v-SRC gene. J Cell Biol 120:757-766.
6. Biasco G, Paganelli GM, Miglioli M, Brillanti S, Di Febo G, Gizzi G, Ponz de leon M, Campieri M, and Barbara L (1990). Rectal cell proliferation and colon cancer risk in ulcerative colitis. Cancer Res 50:1156-1159.
7. Blaschuk OW, Sullivan R, David S, and Pouliot Y (1990). Identification of a cadherin cell adhesion recognition sequence. Dev Biol 139:227-229.
8. Bodmer W, Bishop T, and Karran P (1994). Genetic steps in colorectal cancer. Nat Genet 6:217-219.
9. Brentnall TA, Crispin DA, Rabinovitch PS, Haggitt RC, Rubin CE, Stevens AC, and Burmer GC (1994). Mutations in the p53 gene: An early marker of neoplastic progression in ulcerative colitis. Gastroenterology 107:369-378.
10. Burmer GC, Levine DS, Kulander BG, Haggitt RC, Rubin CE, and Rabinovitch PS (1990). Ki-ras mutations in chronic ulcerative colitis and sporadic colon carcinomas. Gastroenterology 99:416-420.
11. Bussemakers MJG, van Bokhoven A, Smit FP, and Schalken JA (1994). The genes for the calcium dependent cell adhesion molecules P and E cadherin are tandemly arranged in the human genome. Biochem Biophys Res Commun 203: 1291-1294.
12. Cepek KL, Shaw SK, Parker CM, Russell GJ, Morrow JS, Rimm DL, and Brenner MB (1994). Adhesion between epithelial cells and T lymphocytes mediated by E-cadherin and the αEβ7 integrin. Nature 372:190-193.
13. Connell WR, Lennard-Jones JE, Williams CB, Talbot IC, and Wilkinson KH (1994a). Factors affecting the outcome of endoscopic surveillance for cancer in ulcerative colitis. Gastroenterology 107:934-944.
14. Connell WR, Talbot IC, Harper N, Kamm MA, and Lennard-Jones J (1994b). Clinicopathological characteristics of colorectal carcinoma complicating ulcerative colitis. Gut 35: 1419-1423.
15. Dorudi S, Poulsom R, and Hart I (1995). Level of expression of E-cadherin mRNA in colorectal cancer correlates with clinical outcome. Br J Cancer 71:614-616.
16. Dorudi S, Sheffield J, Poulsom R, Northover JMA, and Hart JR (1993). E-cadherin expression in colorectal cancer; an immunohistochemical and in situ hybridization study. Am J Pathol 142:981-986.
17. Fearon ER, Cho KR, Nigro JM, Kern SE, Simons JW, Ruppert IM, Hamilton SR, Preisinger AC, Thomas G, Kinzler KW, and Vogelstein B (1990). Identification of a chromosome 18q gene that is altered in colorectal cancers. Science 247:49-56.
18. Frixen UH, Behrens J, Sachs M, Eberle G, Voss B, Warda A, Lochner D, and Birchmeier W (1991). E-cadherin mediated cell-cell adhesion prevents invasiveness of human carcinoma cells. J Cell Biol 113:173-185.
19. Fujimori T and Takeichi M (1993). Disruption of epithelial cell-cell adhesion by exogenous expression of a mutated nonfunctional N-cadherin. Mol Biol Cell 4:37-47.
20. Gardiner KR, Anderson NH, Rowlands BJ, and Barbul A (1995). Colitis and colonic mucosal barrier dysfunction. Gut 37:530-535.
21. Gilberts EC, Greenstein AJ, Katsei P, Harpaz N, and Greenstein RJ (1994). Molecular evidence for two forms of Crohns disease. Proc Natl Acad Sci USA 91:12721-12724.
22. Goyette MC, Cho K, and Fashing CL (1992). Progression of colorectal cancer is associated with gene defects but inhibition of tumorigenicity is accomplished by correction of any single defect via chromosome transfer. Mol Cell Biol 12: 1387-1395.
23. Hanby AM, Chinery R, Poulsom R, Playford RJ, and Pignatelli M (1996). Downregulation of E-cadherin in the reparative epithelium of the human gastrointestinal tract. Am J Pathol 148:723-729.
24. Hermiston ML and Gordon JI (1995a). In vivo analysis of cadherin function in the mouse intestinal epithelium: Essential roles in adhesion, maintenance of differentiation and regulation of programmed cell death. J Cell Biol 129:489-506.
25. Hermiston ML and Gordon JI (1995b). Inflammatory bowel disease and adenomas in mice expressing a dominant negative N-cadherin. Science 270:1203-1207.
26. Hirano S, Kimoto N, Shimoyama Y, Hirohashi S, and Takeichi M (1992). Identification of a neutral α-catenin as a key regulator of cadherin function and multicellular organization. Cell 70:283-301.
27. Hugot J, Laurent-Puig P, Gower-Rousseau C, Olson JM, Lee JC, Beaugerie L, Naom I, Dupas JL, Van Gossum A, Orholm M, Bonaiti-Pellie C, Weissenbach J, Mathew CG, Lennard-Jones JE, Cortot A, Colombel JF, and Thomas G (1996). Mapping of a susceptibility locus for Crohn's disease on chromosome 16. Nature 379:821-823.
28. James SP and Klapproth JM (1996). Major pathways of mucosal immunity and inflammation; cell activation, cytokine production and role of bacterial factors. Aliment Pharmacol Ther 10:1-9.
29. Jankowski J (1996). Quantitative assessment of gene expression. In: Jankowski J and Polak J, editors: Clinical gene analysis and manipulation: Tools, techniques and trouble-shooting. London, Cambridge University Press, 167-185.
30. Jankowski J, Newham P, Kandemir O, Hirano S, Takeichi M, and Pignatelli M (1994). Differential expression of E-cadherin in normal, metaplastic and dysplastic oesophageal mucosa: A putative biomarker. Int J Oncol 4:441-448.
31. Jenkins D, Goodall A, and Scott BB (1990). Ulcerative colitis: One disease or two (quantitative histological differences between distal and extensive colitis). Gut 31:426-430.
32. Kern SE, Redston M, Seymour AB, Caldas C, Powell SM, Kornacki S, and Kinzler KW (1994). Molecular genetic profiles of colitis-associated neoplasms. Gastroenterology 107:420-428.
33. Kinch MS, Clark GJ, Der CJ, and Burridge K (1995). Tyrosine phosphorylation regulates the adhesions of Ras-transformed breast epithelia. J Cell Biol 150:461-471.
34. Kintner C (1992). Regulation of embryonic cell adhesion by the cadherin cytoplasmic domain. Cell 69:225-236.
35. Korelitz BI (1983). Carcinoma of the intestinal tract in Crohn's disease: Results of a survey conducted by the National Foundation for ileitis and Colitis. Am J Gastroenterol 78:44-46.
36. Lewis JE, Jensen PJ, and Wheelock MJ (1994). Cadherin function is required for human keratinocytes to assemble desmosomes and stratify in response to calcium. Invest Dermatol 102:870-877.
37. Marrs JA, Andersson-Fisone C, Jeong MC, Cohen-Gould L, Zurzolo C, Nabi IR, Rodriguez-Boulan E, and Nelson WJ (1995). Plasticity in epithelial cell phenotype: Modulation by expression of different cadherin cell adhesion molecules. J Cell Biol 129:507-519.
38. McAlindon ME and Mahida YR (1996). Pro-inflammatory cytokines in inflammatory bowel disease. Aliment Pharmacol Ther 10:72-74.
39. Michelassi F, Testa G, Pomidor WJ, Lashner BA, and Block GE (1993). Adenocarcinoma complicating Crohn's disease. Dis Colon Rectum 36:654-661.
40. Munro SB, Turner IM, Farookhi R, Balschuk OW, and Jothy S (1995). E-cadherin and OB cadherin levels in normal colon and colon carcinoma. Exp Mol Pathol 62:118-122.
41. Nagafuchi A, Ishihara S, and Tsukita S (1994). The roles of catenins in the cadherin-mediated cell adhesion: Functional analysis of E-cadherin-α catenin fusion molecules. J Cell Biol 127:235-245.
42. Navarro P, Lozano E, and Cano A (1993). Expression of E and P cadherin is not sufficient to modify the morphology and the tumorigenic behavior of murine spindle carcinoma cells: Possible involvement of plakoglobin. J Cell Sci 105:923-934.
43. Nose A, Nagafuchi A, and Takeichi M (1988). Cadherins in cell sorting. Cell 54:993-997.
44. Nugent FW, Haggitt RC, and Gilpin PA (1991). Cancer surveillance in ulcerative colitis. Gastroenterology 100:1241-1248.
45. Ohshima H and Bartsch HMR (1994). Chronic infections and inflammatory processes as cancer risk factors: Possible role of nitric oxide in carcinogenesis. Mutat Res 305:253-264.
46. Overduin M, Harvey TS, Bagby S, Tong KI, Yau P, Takeichi M, and Ikura M (1995). Solution structure of the epithelial cadherin domain responsible for selective cell adhesion. Science 267:386-389.
47. Ozawa M and Kemler R (1990). Correct proteolytic cleavage is required for the cell adhesive function of uvomorulin. J Cell Biol 111:1645-1650.
48. Ozawa M, Ringwald M, and Kemler R (1990). Uromorulin-catenin complex formation is regulated by a specific domain in the cytoplasmic region of the cell adhesion molecule. Proc Natl Acad Sci USA 87:4246-4250.
49. Palacios J, Benito N, Berraquero R, Pizarro A, Cano A, and Gamallo C (1995). Differential spatiotemporal expression of E and P cadherin during mouse tooth development. Int J Dev Biol 39:663-666.
50. Pallone F and Monteleone G (1996). Regulatory cytokines in inflammatory bowel disease. Aliment Pharmacol Ther 10:75-79.
51. Parkes M, Satsangi J, Lathrop GM, Bell JI, and Jewell DP (1996). Susceptibility loci in inflammatory bowel disease (letter). Lancet 348:1588.
52. Playford RJ, Marchbank T, Chinery R, Evison R, Pignatelli M, Boulton R, Thim L, and Hanby AM (1995). Human spasmolytic polypeptide is a cytoprotective agent which stimulates cell migration. Gastroenterology 108:108-116.
53. Redston MS, Papadopoulos N, Caldas C, Kinzler KW, and Kern SE (1995). Common occurrence of APC and K-ras gene mutations in the spectrum of colitis-associated neoplasias. Gastroenterology 108:383-392.
54. Riddell RH, Goldman H, Ransohoff DF, Appelman HD, Fenoglio CM, Haggitt RC, Ahren C, Correa P, Hamilton SR, Morson BC, Sommers SC, and Yardley JH (1983). Dysplasia in inflammatory bowel disease: Standardized classification with provisional clinical applications. Hum Pathol 14:931-968.
55. Risinger JI, Berchuck A, Kohler ME, and Boyd J (1994). Mutations of the E-cadherin gene in human gynecologic cancers. Nat Genet 7:98-102.
56. Senior PV, Critchley DR, Beck F, Walker RA, and Varley JM (1988). The localization of laminin mRNA and protein in the postimplantation embryo and placenta of the mouse: An in situ hybridization and immunocytochemical study. Development 104:431-446.
57. Shapiro L, Fannon AM, Kwong PD, Thompson A, Lehmann MS, Grubel G, Legrand JF, Alsnielsen J, Colman DR, and Hendrickson WA (1995). Structural basis of cell-cell adhesion by cadherins. Nature 374:327-337.
58. Sokoloff MH, Tso CL, Kaboo R, Taneja S, Pang S, deKernion JB, and Belldegrun AS (1996). In vitro modulation of tumor progression associated properties of hormone refractory prostate carcinoma cell lines by cytokines. Cancer 77:1862-1872.
59. Steinberg MS and Takeichi M (1994). Experimental specification of cell sorting, tissue spreading and specific spatial patterning by quantitative differences in cadherin expression. Proc Natl Acad Sci USA 91:206-209.
60. Takeichi M (1991). Cadherin cell adhesion receptors as a morphogenetic regulator. Science 251:1451-1455.
61. Takeichi M (1993). Cadherins in cancer: Implications for invasion and metastasis. Curr Opin Cell Biol 5:806-811.
62. Talbot IC (1996). Redetection and growth of colorectal polyps (comment). Gut 39:492.
63. Tomschy A, Fauser C, Landwehr R, and Engel J (1996). Homophilic adhesion of E-cadherin occurs by a co-operative two-step interaction of N-terminal domains. EMBO J 15: 3507-3514.
64. Tsuji M and Dubois RN (1995). Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxidase synthase 2. Cell 83:493-501.
65. Tsukita S, Itoh M, Nagafuchi S, and Tsukita S (1993). Submembranous junctional plaque proteins include potential tumor suppressor molecules. J Cell Biol 123:1049-1053.
66. Vleminckx K, Vakaet L, Mareel M, Fiers W, and Van Roy F (1991). Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role. Cell 66:107-119.
67. Vogelstein B and Kinzler KW (1992). p53 function and dysfunction. Cell 70:523-526.
68. Willenbucher RF (1996). Inflammatory bowel disease. Semin Gastrointest Dis 7:94-104.